BraveHoods for brave kids

Article

Elizabeth Whittington blog image

Several companies have adopted the "one for one" idea after the philanthropic success of TOMS, the shoe company that donates one pair of shoes to a child in need when you buy a pair of their espadrilles. In honor of Childhood Cancer Awareness Month, we wanted to point out another organization that is doing good. BraveHoods may not be on the same scale as TOMS, but its one-for-one campaign of delivering comfortable clothing to kids with cancer--and their siblings--while also bringing attention to childhood cancer is worth noting.Allison Yacht started BraveHoods in June 2013 in response to her daughter's cancer diagnosis and treatment. "One of the hardest things for her was going out and about when she was bald. We struggled for some time to try to make her more comfortable and finally found that a hoodie t-shirt worked perfectly," she says. "It is an easy and inconspicuous way for her to feel like she fit in."Yacht realized that other kids might be having the same issues and created BraveHoods, a clothing line that featured soft clothing with inspirational messages--with hoodies. Yacht said her first goal was to help kids with pediatric cancers be more comfortable. In her experience, she noted children didn't like hat, scarves or wigs, and being bald made them feel "on display." What most kids appreciated were hoodies, which are popular even with kids without hair loss. Her second goal was to create a business model where families dealing with cancer could receive one for free. When people purchase a BraveHood, Yacht donates one to a kid with cancer. Currently, they have given away almost 700 shirts. "We also donate to siblings because we know that they can get lost in the shuffle sometimes," she says. Yacht has made a goal to donate 1300 shirts. "We picked this number because there are 13,000 kids diagnosed each year and we want to reach just 10 percent of these kids," she says. Currently, BraveHoods are distributed through families contacting Yacht individually, as well as through Children's Hospital Colorado, Rocky Mountain Children's Health Foundation and Bags of Fun. Soon, BraveHoods will be going to Memorial Sloan-Kettering Cancer Center, St. Jude Children's Research Hospital and the Jimmy Fund. To learn more, you can visit BraveHoods.com.

Related Videos
Image of Meaghan Mooney at the 2024  Extraordinary Healer Award event.
Video 4 - "Current First-Line Treatment Options in CLL"
Video 3 - "Goals of Treatment for Patients With CLL"
Image of a woman with short blonde hair wearing a white blazer.
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Yuliya P.L Linhares, MD, an expert on CLL
Yuliya P.L Linhares, MD, and Josie Montegaard, MSN, AGPCNP-BC, experts on CLL
Related Content